The partners join a deep bench of health-system investors, including Providence, Kaiser Permanente, and Mass-General Brigham. Backed by industry insiders, DexCare has the capital runway to accelerate market adoption of its care orchestration platform, which enables health systems to serve more patients with the same clinical resources.

The additional partners come as part of DexCare's Series C funding round led by ICONIQ Growth, which earmarked investment from U.S. health systems.

DexCare is a Platform-as-a-Service (PaaS) for health systems that intelligently orchestrates digital demand and health system capacity across all lines of care. In a complex and vast sea of virtual point solutions, DexCare is the operating system that makes it all work. DexCare's data-driven intelligence engine allocates, flexes and optimizes resources to best meet both consumer demand and health system business goals-expanding the reach of health system service lines into a new, digital and on-demand consumer arena. The platform attracts and caters to high-value consumers by providing a fully-digitized, unified experience that routes consumers to the best care options while leveraging existing EMR, caregiver and brand investments.